C

AR-T immunotherapy, in which a body’s own T cells are reengineered to attack a patient’s tumor, has picked up steam in recent years. But T cells aren’t the only immune cells that scientists are tinkering with.

A team of researchers from the University of Central Florida has found that “natural killer cells” in the body may also play a compelling role in attacking cancer. It may be possible to enhance that response by taking immune cells from a cancer patient’s close blood relatives and infusing those into the patient to attack their tumors. Unlike CAR-T therapy, which so far is restricted to use in blood cancers, there’s hope that these NK cells could be used to treat solid tumors as well.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy